Transient increase of DN1 and decrease of DN2, DN3 showed in <i>the Foxn1</i>^<i>lacZ</i> thymus. by Shiyun Xiao (75798)

Fig 5 - by Daksh Arora (16510065)

Image_2_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

“…Extracorporeal life support was used more often in patients treated with CDT, compared to ST (0.5 vs. 0.2%, OR = 2.52, 95% CI 1.88–3.39, p < 0.001). …”

Toroidal metamaterials. by Wen-Ying Zhou (10049543)

“…Initially, we employ COMSOL software to design a MIMO mobile terminal antenna that meets 2G, 3G, 4G, and 5G communication requirements. …”

Human tissue dielectric parameters. by Wen-Ying Zhou (10049543)

“…Initially, we employ COMSOL software to design a MIMO mobile terminal antenna that meets 2G, 3G, 4G, and 5G communication requirements. …”

Human head modeling. by Wen-Ying Zhou (10049543)

“…Initially, we employ COMSOL software to design a MIMO mobile terminal antenna that meets 2G, 3G, 4G, and 5G communication requirements. …”

Variations in SAR for individual organizations. by Wen-Ying Zhou (10049543)

“…Initially, we employ COMSOL software to design a MIMO mobile terminal antenna that meets 2G, 3G, 4G, and 5G communication requirements. …”

Knockdown of AR expression decreases the efficiency of KSHV infection in endothelial cells. by Xing Wang (154377)

“…(g, h) Knockdown of AR and EphA2 expression decreases nuclear LANA expression in SLK cells, as determined by an immunofluorescence assay and quantitative analysis by Image J software. …”

Raw data of the charts in Fig 5. by Kam Pui Tam (19746865)

“…Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”

Simulation of the optimal control P2 using <i>ω</i>₁ = 1, <i>ω</i>₂ = .5 and <i>u</i>_<i>max</i> = 10. by Maria C. A. Leite (5586701)

Image of SIVA grading platform. by Ling-Jun Li (729635)

The <i>AtTIFY10a/b</i> knockout mutant <i>Arabidopsis</i> showed decreased alkaline tolerance at the seed germination stage. by Dan Zhu (139675)

Classification and regression tree: CYP3A5 phenotype discriminates between cases and tolerants (EM = normal metabolizers, IM and PM = decrease function, UM and UMH = increase function). by Luciana Kase Tanno (785410)

“…<p>Classification and regression tree: CYP3A5 phenotype discriminates between cases and tolerants (EM = normal metabolizers, IM and PM = decrease function, UM and UMH = increase function).…”

<i>Fkbp5</i> DNA methylation decreases with age in mice. by Jonathan J. Sabbagh (626366)

S1 File - by Sho Sugahara (11895828)

“…Although we found an increase in Myc, a positive regulator of both ribosomal and mitochondrial biogenesis, decreased levels of NRF1 and TFAM, positive regulators of mitochondrial biogenesis whose gene expression is directory activated by Myc, were paradoxically observed. …”

The authorship rating was a 6-point rating scale of the degree of authorship, ranging from 1 “I could not manipulate the window at all” to 6 “I completely manipulated the window”.... by Junhui Kim (18575083)

RTs (in ms, bars) and ACC (in%, line) across time points, with 95% confidence interval. by Marcel F. Hinss (14675457)

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”